1983
DOI: 10.1016/0002-9610(83)90356-2
|View full text |Cite
|
Sign up to set email alerts
|

Bovine carotid artery heterografts versus polytetrafluoroethylene grafts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
20
0
2

Year Published

1986
1986
2020
2020

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(22 citation statements)
references
References 12 publications
0
20
0
2
Order By: Relevance
“…Biomaterials adapted for vascular tissue engineering include animal-derived biopolymer gels such as collagen [6], fibrin [79], or composites [10]; biodegradable polymers such as polylactic acid, polyglutamic acid, polycaprolactone, polyurethanes, and their copolymers or composite structures [1118]; and decellularized natural tissues [1926]. The assembly of cell-populated haemodialysis access grafts from extracellular matrix (ECM) proteins secreted by autologous cells, with no foreign biomaterial, is currently one of the most advanced arterial tissue engineering technologies [27].…”
Section: Introductionmentioning
confidence: 99%
“…Biomaterials adapted for vascular tissue engineering include animal-derived biopolymer gels such as collagen [6], fibrin [79], or composites [10]; biodegradable polymers such as polylactic acid, polyglutamic acid, polycaprolactone, polyurethanes, and their copolymers or composite structures [1118]; and decellularized natural tissues [1926]. The assembly of cell-populated haemodialysis access grafts from extracellular matrix (ECM) proteins secreted by autologous cells, with no foreign biomaterial, is currently one of the most advanced arterial tissue engineering technologies [27].…”
Section: Introductionmentioning
confidence: 99%
“…5 The use of bovine carotid artery (BCA) heterograft for hemodialysis access was first reported by Chinitz et al 6 and was used extensively by many centers in the 1970s. [7][8][9][10][11][12][13][14][15][16] However, with the advent of ePTFE grafts later that decade, BCA grafts fell out of favor despite the lack of data to account for the change in paradigm. 16 With the efficient and effective endovascular techniques now available to manage complications along with improvements to BCA manufacturing, we felt revisiting BCAs as AV conduits for hemodialysis would be worthwhile.…”
mentioning
confidence: 99%
“…The use of BCA biological grafts began in the 1970; however, their use declined with the development of grafts made from synthetic polymers such as ePTFE. [10][11][12][13][14][15] Although ePTFE conduits remain the dominant AVG in use today, resurgence in the use of biologic grafts has been observed. This retrospective study presents an extensive investigation of differences in outcomes between BCA and ePTFE vascular access conduits as well as insight into factors limiting graft patency.…”
Section: Discussionmentioning
confidence: 99%